About Us
Mission & History
Business Model
Donors
Governance
Stakeholders
Scientific Advisors
Team
Jobs
Why New Drugs Now?
Threat of TB
Outdated Treatment
TB-HIV
Drug-Resistant TB
The Poverty Cycle
Developing New Treatments
Portfolio
Critical Path to TB Regimens
Strategic Initiatives
Regulatory Engagement
Adoption & Availability
AAA Mandate
Working with Constituencies
Engaging Policymakers
Laying the Groundwork
NewsCenter
News from the TB Alliance
News About Us
Latest TB News
Publications
Multimedia
Resources
Events
Media Support
Contact Us
To receive a copy of our 2010 Annual Report by mail, please fill out the information below:
Your Name
Company
Your Email
Address
City
State or Province
Zip or Postal Code
Country
How many copies?
Comments
click here to submit your request
Search:
SEARCH
Media Support Section
click here
For additional information please email:
newsmedia@tballiance.org
Half-century-old TB drugs get a facelift in new cocktails
12/01/2010
WHO says deadly TB scourge preventable
11/11/2010
David Brennan of AstraZeneca says public sector crucial to drug research
10/11/2010
Regulatory Conference Shows The Way Forward From Lessons Learnt In The Past
8/19/2010
Anti-TB compounds could fight neglected diseases
7/07/2010
click to view all items
2010 TB Alliance Annual Report
More Than Ever
April 2011 Newsletter
Click to view the newsletter
Falling Short: Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis
TB Alliance 2009 Financial Statement
©2001-2012 Global Alliance for TB Drug Development. All Rights Reserved.